In silico prediction of blood-brain barrier permeation

Drug Discovery Today

Volumn 8, Issue 20, 2003, Pages 927-933

  Clark, David E ^a  

^a Argenta Discovery Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; BLOOD BRAIN BARRIER; COMPUTER MODEL; DATA ANALYSIS; LIPOPHILICITY; MOLECULAR DYNAMICS; MOLECULAR SIZE; MOLECULAR WEIGHT; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREDICTION; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW; STEADY STATE;

ALGORITHMS; BLOOD-BRAIN BARRIER; DRUG DESIGN; MODELS, BIOLOGICAL; PERMEABILITY; PHARMACOKINETICS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0141958109     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(03)02827-7     Document Type: Review

References (33)

1. Venkatesh S., Lipper R.A. Role of the development scientist in compound lead selection and optimization. J. Pharm. Sci. 89:2000;145-154.
2. Pardridge W.M. Drug and gene targeting to the brain with molecular Trojan horses. Nat. Rev. Drug Discov. 1:2002;131-139.
3. Tamai I., Tsuji A. Transporter-mediated permeation of drugs across the blood-brain barrier. J. Pharm. Sci. 89:2000;1371-1388.
4. Demeule M., et al. Drug transport to the brain: key roles for the efflux pump P-glycoprotein in the blood-brain barrier. Vascul. Pharmacol. 38:2002;339-348.
5. Eisenblatter T., et al. Characterisation of the brain multidrug resistance protein (BMDP/ABCG2/BCRP) expressed at the blood-brain barrier. Brain Res. 971:2003;221-231.
6. Lundquist S., Renftel M. The use of in vitro cell culture models for mechanistic studies and as permeability screens for the blood-brain barrier in the pharmaceutical industry: background and current status in the drug discovery process. Vascul. Pharmacol. 38:2002;355-364.
7. Gratton J.A., et al. Molecular factors influencing drug transfer across the blood-brain barrier. J. Pharm. Pharmacol. 49:1997;1211-1216.
8. Platts J.A., et al. Correlation and prediction of a large blood-brain distribution data set: an LFER study. Eur. J. Med. Chem. 36:2001;719-730.
9. Norinder U., Haeberlein M. Computational approaches to the prediction of blood-brain distribution. Adv. Drug Deliv. Rev. 54:2002;291-313.
10. Atkinson F., et al. Lipophilicity and other parameters affecting brain permeation. Curr. Med. Chem. 2:2002;229-240.
11. Clark D.E. Prediction of intestinal absorption and blood-brain barrier permeation by computational methods. Comb. Chem. High Throughput Screen. 4:2001;477-496.
12. van de Waterbeemd H., et al. Estimation of blood-brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptors. J. Drug Target. 6:1998;151-165.
13. Kelder J., et al. Polar molecular surface area as a dominating determinant for oral absorption and brain permeation of drugs. Pharm. Res. 16:1999;1514-1519.
14. Doan K.M., et al. Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs. J. Pharmacol. Exp. Ther. 303:2002;1029-1037.
15. Seelig A., et al. A method to determine the ability of drugs to diffuse through the blood-brain barrier. Proc. Natl. Acad. Sci. U. S. A. 91:1994;68-72.
16. Ajay, et al. Designing libraries with CNS activity. J. Med. Chem. 42:1999;4942-4951.
17. Crivori P., et al. Predicting blood-brain barrier permeation from three-dimensional molecular structure. J. Med. Chem. 43:2000;2204-2216.
18. Keseru G.M., et al. A neural network based virtual high throughput screening test for the prediction of CNS activity. Comb. Chem. High Throughput Screen. 3:2000;535-540.
19. Doninger S., et al. Predicting CNS permeability of drug molecules: comparison of neural network and support vector machine algorithms. J. Comput. Biol. 9:2002;849-864.
20. Engkvist O., et al. Prediction of CNS activity of compound libraries using substructure analysis. J. Chem. Inf. Comput. Sci. 43:2003;155-160.
21. Kaznessis Y.N., et al. Prediction of blood-brain partitioning using Monte Carlo simulations of molecules in water. J. Comput. Aided Mol. Des. 15:2001;697-708.
22. Ooms F., et al. A simple model to predict blood-brain barrier permeation from 3D molecular fields. Biochim. Biophys. Acta. 1587:2002;118-125.
23. Rose K., et al. Modeling blood-brain barrier partitioning using the electrotopological state. J. Chem. Inf. Comput. Sci. 42:2002;651-666.
24. Iyer M., et al. Predicting blood-brain barrier partitioning of organic molecules using membrane-interaction QSAR analysis. Pharm. Res. 19:2002;1611-1621.
25. Lobell M., et al. Recent advances in the prediction of blood-brain partitioning from molecular structure. J. Pharm. Sci. 92:2003;360-370.
26. Conradi R.A., et al. Physico-chemical and biological factors that influence a drug's cellular permeability by passive diffusion. Pliška V., et al. Lipophilicity in Drug Action and Toxicology. 1996;233-252 VCH.
27. Fischer H., et al. Blood-brain barrier permeation: molecular parameters governing passive diffusion. J. Membr. Biol. 165:1998;201-211.
28. Palm K., et al. Effect of molecular charge on intestinal epithelial drug transport: pH-dependent transport of cationic drugs. J. Pharmacol. Exp. Ther. 291:1999;435-443.
29. Austin R.P., et al. Partitioning of ionizing molecules between aqueous buffers and phospholipid vesicles. J. Pharm. Sci. 84:1995;1180-1183.
30. Veber D.F., et al. Molecular properties that influence the oral bioavailability of drug candidates. J. Med. Chem. 45:2002;2615-2623.
31. Abbott N.J., et al. Delivery of imaging agents into brain. Adv. Drug Deliv. Rev. 37:1999;253-277.
32. Hume S.P., Myers R. Dedicated small animal scanners: a new tool for drug development? Curr. Pharm. Des. 8:2002;1497-1511.
33. Feng M.R. Assessment of blood-brain barrier permeation: in silico, in vitro and in vivo. Curr. Drug Metab. 3:2002;647-657.